PsychPartnersPsychPartners
 
PsychPartnersPsychPartners
New Patients
  • Providers & Locations
    • Providers
    • Locations
  • Self Help
    • Self Help Blog
    • Research for the Public
    • Lifestyle
    • Supplements
    • Psych Meds
    • Pocket Psychiatrist Podcast
    • Depression & Bipolar Workbook
  • Psych Education
    • Research Updates
      • Daily Psych Blog
      • Top Research
      • LinkedIn
      • Facebook
      • X
      • Bluesky
    • Books
    • Carlat Psych Podcast
    • Talks
  • Join our Team
    • Primary Care Partners
    • Therapy Partners
    • Employment
  • Contact
FDA Moves the Goalposts on Alcohol Treatment
Addiction MedsAlcoholResearchSubstance Use

FDA Moves the Goalposts on Alcohol Treatment

June 2, 2026by Chris Aiken, MD0
A GLP-1 Trial Changes the Score in Alcohol
AlcoholGLP1 AgonistsMedicationsResearchResearch for the PublicSubstance UseTop Research

A GLP-1 Trial Changes the Score in Alcohol

May 5, 2026by Chris Aiken, MD0
Naltrexone-Baclofen Combo for Alcohol Craving
Addiction MedsAlcoholMedicationsResearchSubstance UseTop Research

Naltrexone-Baclofen Combo for Alcohol Craving

April 28, 2026by Chris Aiken, MD1
Low Dose Naltrexone in Depression
Addiction MedsDepressionInflammationResearch

Low Dose Naltrexone in Depression

March 23, 2026by Chris Aiken, MD0
Top Studies
All Studies
Self Help

Recent Posts

  • June 3, 2026Olanzapine May Raise Liver Enzymes

  • June 2, 2026TMS for Anorexia and Bulimia

  • June 2, 2026FDA Moves the Goalposts on Alcohol Treatment

  • June 2, 2026Melatonin Protects Before ECT

  • June 1, 2026Smartphones in Borderline Personality Disorder: Friend and Foe

Categories

  • Addiction Meds
  • ADHD
  • Alcohol
  • Antidepressants
  • Antipsychotics
  • Anxiety
  • Autism
  • Benzodiazepines
  • Bipolar
  • Bipolar Meds
  • Cannabis
  • Child Psychiatry
  • Clozapine
  • Cocaine
  • Cognition
  • Dementia
  • Deprescribing
  • Depression
  • Devices
  • Difficult to Treat Depression
  • Disorders
  • Eating Disorders
  • ECT
  • Exercise
  • Geriatric Psychiatry
  • GLP1 Agonists
  • Hypnotics
  • Inflammation
  • Ketamine
  • Lifestyle
  • Light Therapy
  • Lithium
  • Med-Psych
  • Medications
  • Methamphetamine
  • Neuromodulation/TMS
  • Nutrition
  • OCD
  • Opioids
  • Personality Disorders
  • Psychedelics
  • PTSD
  • Research
  • Research for the Public
  • Schizophrenia and Psychosis
  • Sedatives
  • Side Effects
  • Sleep
  • Stimulants
  • Substance Use
  • Supplements
  • Therapy
  • Top Research
  • Women's Health
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/floating_image_02.png?fit=161%2C245&ssl=1
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/floating_image_03.png?fit=84%2C96&ssl=1
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/floating_image_10.png?fit=75%2C84&ssl=1
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/SquareLogoMediumThumn-min.jpg?resize=160%2C160&ssl=1

Collaborative mental health

©2025 Psych Partners USA | Terms of use | Cookie policy

Career opportunities
Chris Aiken, MD
LINKS
  • About us
    • Chris Aiken, MD
    • Team
    • Contact
    • Locations
ADMINISTRATIVE TEAM

Nancy Brandon,
Director of Operations

2016 Ashburn Lane
Clemmons, NC 27012

(336) 948-1876

nancy.brandon@psych-partners.com

ADMIN HOURS

Mon – Fri: 9am-5pm EST
Sat – Sun: Closed

bt_bb_section_top_section_coverage_image